Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Thomas, Douglas D. / Turk, Boris / Wittinghofer, Alfred


IMPACT FACTOR 2018: 3.014
5-year IMPACT FACTOR: 3.162

CiteScore 2018: 3.09

SCImago Journal Rank (SJR) 2018: 1.482
Source Normalized Impact per Paper (SNIP) 2018: 0.820

Online
ISSN
1437-4315
See all formats and pricing
More options …
Volume 392, Issue 10

Issues

Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections

Stephan Ludwig
  • Institute of Molecular Virology (IMV), Centre for Molecular Biology of Inflammation (ZMBE), University of Münster, Von-Esmarch-Str. 56, D-48149 Münster, Germany
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2012-07-26 | DOI: https://doi.org/10.1515/BC.2011.121

Abstract

Influenza is still one of the major plagues worldwide with the threatening potential to cause pandemics. In recent years, increasing levels of resistance to the four FDA approved anti-influenza virus drugs have been described. This situation underlines the urgent need for novel anti-virals in preparation for future influenza epidemics or pandemics. Although the anti-virals currently in use target viral factors such as the neuraminidase or the M2 ion channel, there is an increase in pre-clinical approaches that focus on cellular factors or pathways that directly or indirectly interact with virus replication. This does not only include inhibitors of virus-supportive signaling cascades but also interaction blockers of viral proteins with host cell proteins. This review aims to highlight some of these novel approaches that represent a paradigm change in anti-viral strategies against the influenza virus. Although most of these approaches are still in an early phase of preclinical development they might be very promising particularly with respect to the prevention of viral resistance to potential drugs.

Keywords: anti-viral drugs; influenza A virus; natural products; signal transduction; virus-cell interaction

About the article

Corresponding author


Received: 2011-03-08

Accepted: 2011-07-27

Published Online: 2012-07-26

Published in Print: 2011-10-01


Citation Information: Biological Chemistry, Volume 392, Issue 10, Pages 837–847, ISSN (Online) 1437-4315, ISSN (Print) 1431-6730, DOI: https://doi.org/10.1515/BC.2011.121.

Export Citation

©2011 by Walter de Gruyter Berlin Boston.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Christian Wiwie, Irina Kuznetsova, Ahmed Mostafa, Alexander Rauch, Anders Haakonsson, Inigo Barrio-Hernandez, Blagoy Blagoev, Susanne Mandrup, Harald H.H.W. Schmidt, Stephan Pleschka, Richard Röttger, and Jan Baumbach
Systems Medicine, 2019, Volume 2, Number 1, Page 1
[2]
Andrés Pizzorno, Olivier Terrier, Claire Nicolas de Lamballerie, Thomas Julien, Blandine Padey, Aurélien Traversier, Magali Roche, Marie-Eve Hamelin, Chantal Rhéaume, Séverine Croze, Vanessa Escuret, Julien Poissy, Bruno Lina, Catherine Legras-Lachuer, Julien Textoris, Guy Boivin, and Manuel Rosa-Calatrava
Frontiers in Immunology, 2019, Volume 10
[3]
Jason Kindrachuk, Britini Ork, Brit J. Hart, Steven Mazur, Michael R. Holbrook, Matthew B. Frieman, Dawn Traynor, Reed F. Johnson, Julie Dyall, Jens H. Kuhn, Gene G. Olinger, Lisa E. Hensley, and Peter B. Jahrling
Antimicrobial Agents and Chemotherapy, 2015, Volume 59, Number 2, Page 1088
[4]
L. Josset, V. D. Menachery, L. E. Gralinski, S. Agnihothram, P. Sova, V. S. Carter, B. L. Yount, R. L. Graham, R. S. Baric, and M. G. Katze
mBio, 2013, Volume 4, Number 3
[5]
Andrea Rückle, Emanuel Haasbach, Ilkka Julkunen, Oliver Planz, Christina Ehrhardt, and Stephan Ludwig
Journal of Virology, 2012, Volume 86, Number 18, Page 10211
[6]
L. Zhu, H. Ly, and Y. Liang
Journal of Virology, 2014, Volume 88, Number 1, Page 417
[8]
Huifang Cao, Fajun Han, Jinchao Tan, Mingyu Hou, Yuanxing Zhang, Dahai Yang, Qin Liu, and Shelley M. Payne
Infection and Immunity, 2018, Volume 86, Number 9
[9]
Valeria Francesconi, Luca Giovannini, Matteo Santucci, Elena Cichero, Maria Paola Costi, Lieve Naesens, Fabrizio Giordanetto, and Michele Tonelli
European Journal of Medicinal Chemistry, 2018
[10]
Fryad Rahman, Mohammad Chebbo, Noémie Courtin, Aurelien Fotso Fotso, Marie-Christine Alessi, and Béatrice Riteau
International Journal of Molecular Sciences, 2018, Volume 19, Number 5, Page 1400
[11]
Magdalena Holzberg, Yvonne Boergeling, Tobias Schräder, Stephan Ludwig, and Christina Ehrhardt
Frontiers in Microbiology, 2017, Volume 8
[12]
Julie Dyall, Robin Gross, Jason Kindrachuk, Reed F. Johnson, Gene G. Olinger, Lisa E. Hensley, Matthew B. Frieman, and Peter B. Jahrling
Drugs, 2017
[13]
Marie-Christine Alessi, Nicolas Cenac, Mustapha Si-Tahar, and Béatrice Riteau
Frontiers in Microbiology, 2017, Volume 8
[14]
Emanuel Haasbach, Christin Müller, Christina Ehrhardt, Andre Schreiber, Stephan Pleschka, Stephan Ludwig, and Oliver Planz
Antiviral Research, 2017, Volume 142, Page 178
[15]
Georgetta Cannon, Michelle A. Callahan, Jenny Q. Gronemus, R. Joel Lowy, and Andrew Pekosz
PLoS ONE, 2014, Volume 9, Number 8, Page e105385
[16]
Yuewen Ding, Lijuan Zeng, Runfeng Li, Qiaoyan Chen, Beixian Zhou, Qiaolian Chen, Pui leng Cheng, Wang Yutao, Jingping Zheng, Zifeng Yang, and Fengxue Zhang
BMC Complementary and Alternative Medicine, 2017, Volume 17, Number 1
[17]
Carolin Klemm, Christin Bruchhagen, Andre van Krüchten, Silke Niemann, Bettina Löffler, Georg Peters, Stephan Ludwig, and Christina Ehrhardt
Scientific Reports, 2017, Volume 7, Page 42473
[18]
Rüdiger Dierkes, Kathrin Warnking, Swantje Liedmann, Roman Seyer, Stephan Ludwig, Christina Ehrhardt, and Oliver Schildgen
PLoS ONE, 2014, Volume 9, Number 2, Page e88520
[19]
Martin Hölzer, Verena Krähling, Fabian Amman, Emanuel Barth, Stephan H. Bernhart, Victor A. O. Carmelo, Maximilian Collatz, Gero Doose, Florian Eggenhofer, Jan Ewald, Jörg Fallmann, Lasse M. Feldhahn, Markus Fricke, Juliane Gebauer, Andreas J. Gruber, Franziska Hufsky, Henrike Indrischek, Sabina Kanton, Jörg Linde, Nelly Mostajo, Roman Ochsenreiter, Konstantin Riege, Lorena Rivarola-Duarte, Abdullah H. Sahyoun, Sita J. Saunders, Stefan E. Seemann, Andrea Tanzer, Bertram Vogel, Stefanie Wehner, Michael T. Wolfinger, Rolf Backofen, Jan Gorodkin, Ivo Grosse, Ivo Hofacker, Steve Hoffmann, Christoph Kaleta, Peter F. Stadler, Stephan Becker, and Manja Marz
Scientific Reports, 2016, Volume 6, Number 1
[20]
Sabine Eva Dudek, Katja Nitzsche, Stephan Ludwig, and Christina Ehrhardt
Scientific Reports, 2016, Volume 6, Number 1
[21]
Clyde Dapat and Hitoshi Oshitani
Expert Review of Anti-infective Therapy, 2016, Volume 14, Number 3, Page 285
[22]
Huachen Gan, Qin Hao, Steven Idell, and Hua Tang
Scientific Reports, 2016, Volume 5, Number 1
[23]
Ryohei Nakada, Hidemi Hirano, and Yoshiyuki Matsuura
Scientific Reports, 2015, Volume 5, Page 15055
[24]
Eike R. Hrincius, Swantje Liedmann, Darisuren Anhlan, Thorsten Wolff, Stephan Ludwig, and Christina Ehrhardt
Cellular Microbiology, 2014, Volume 16, Number 12, Page 1854
[25]
Parvaneh Mehrbod, Abdul Rahman Omar, Mohd Hair-Bejo, Amin Haghani, and Aini Ideris
BioMed Research International, 2014, Volume 2014, Page 1
[26]
Jake Dunning, J Kenneth Baillie, Bin Cao, and Frederick G Hayden
The Lancet Infectious Diseases, 2014, Volume 14, Number 12, Page 1259
[27]
H. Connaris, E. A. Govorkova, Y. Ligertwood, B. M. Dutia, L. Yang, S. Tauber, M. A. Taylor, N. Alias, R. Hagan, A. A. Nash, R. G. Webster, and G. L. Taylor
Proceedings of the National Academy of Sciences, 2014, Volume 111, Number 17, Page 6401
[28]
B. J. Hart, J. Dyall, E. Postnikova, H. Zhou, J. Kindrachuk, R. F. Johnson, G. G. Olinger, M. B. Frieman, M. R. Holbrook, P. B. Jahrling, and L. Hensley
Journal of General Virology, 2014, Volume 95, Number Pt_3, Page 571
[29]
Ji-Hye Lee, Sun Young Bae, Mi Oh, Kyung Hyun Kim, and Mi Sook Chung
Foodborne Pathogens and Disease, 2014, Volume 11, Number 3, Page 224
[30]
Clyde Dapat, Reiko Saito, Hiroshi Suzuki, and Tsuneyoshi Horigome
Virus Research, 2014, Volume 179, Page 53
[31]
Anaïs Legand, Sylvie Briand, Nikki Shindo, W Abdullah Brooks, Menno D de Jong, Jeremy Farrar, Ximena Aguilera, and Frederick G Hayden
Future Virology, 2013, Volume 8, Number 10, Page 953
[32]
David S. Fedson
Antiviral Research, 2013, Volume 99, Number 3, Page 417
[33]
Emanuel Haasbach, Sarah Julia Reiling, Christina Ehrhardt, Karoline Droebner, Andrea Rückle, Eike R. Hrincius, Johann Leban, Stefan Strobl, Daniel Vitt, Stephan Ludwig, and Oliver Planz
Antiviral Research, 2013, Volume 99, Number 3, Page 336
[34]
Emanuel Haasbach, Carmen Hartmayer, and Oliver Planz
Antiviral Research, 2013, Volume 98, Number 2, Page 319
[35]
Frederick G. Hayden
Influenza and Other Respiratory Viruses, 2013, Volume 7, Page 63
[36]
Patchima Sithisarn, Martin Michaelis, Manfred Schubert-Zsilavecz, and Jindrich Cinatl
Antiviral Research, 2013, Volume 97, Number 1, Page 41
[38]
Qi Zhou, Meng Zhu, Hao Zhang, Ting Yi, John D. Klena, and Yihong Peng
Virus Research, 2012, Volume 169, Number 1, Page 91
[39]
Qiong Xue and Kathryn Miller-Jensen
BMB Reports, 2012, Volume 45, Number 4, Page 213
[40]
Bo Wang, Hao Zhang, Meng Zhu, Zhijun Luo, and Yihong Peng
Antiviral Research, 2012, Volume 93, Number 1, Page 110

Comments (0)

Please log in or register to comment.
Log in